Showing results (541-550 of 586) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2015
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug AdministrationJean Sebastien Frenel, Suzanne Carreira, Jane Goodall, et al.
Journal of Immunotherapy and Precision Oncology|February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I TrialMirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
JAMA Network Open|July 16, 2026
Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck CancerHarold Nathan Tan, Bettzy Stephen, Oriol Mirallas, et al.
Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.
The Oncologist|April 24, 2025
Barriers to publishing early phase clinical trials: the oncologists' perspectiveMerel J J Lucassen, Pedro Bergmann, Olga Husson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkersTimothy A Yap, Li Yan, Amita Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced CancerTimothy A Yap, Maria Vieito, Capucine Baldini, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
HER2-low expression in patients with advanced or metastatic solid tumorsB Uzunparmak, C Haymaker, G Raso, et al.
NPJ Precision Oncology|October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncologyHenry Hiep Vo, Siqing Fu, David S Hong, et al.
Pageof 59